Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) currently has a daily average trading volume of 3.26M but it saw 2197090 shares traded in last market. With a market cap of 95.31M USD, the company’s current market price of $0.59 came falling about -9.72 while comparing to the previous closing price of $0.65. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.11 and as low as $0.53.
Over the week, IRWD’s stock price is moving -9.24% down while it is -18.13% when we observe its performance for the past one month. Year-to-date it is -86.70% down and over the past year, the stock is showing a downside performance of -90.91%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0.04 while estimate for next year EPS is 0.19. In next quarter, company is expected to be making quarterly sales of $77.82M as analysts are expecting the sales for current fiscal year at $269.28M and seeing the company making $258.74M in sales next year. Moreover, analysts are in estimates of $62.02M for current-quarter revenue.
Currently, Ironwood Pharmaceuticals Inc’s total number of outstanding shares is 161.81M with 2.53% of that held by the insiders while 97.46% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -12.00% and return on equity (ROE) at -559.14%. It has a 1.66 of forward P/E ratio. Stock’s beta reads 0.27. Stock has a price to sale or P/S ratio amounts to 0.30. Its return on asset (ROA) is -8.20% on average.
